(VIANEWS) – Shares of ABL Diagnostics (CAC 40: ABLD.PA) fell by a staggering 26.52% in 10 sessions from €11.84 to €8.70 at 19:39 EST on Friday, after five sequential sessions in a row of losses. CAC 40 is falling 1.43% to €6,925.40, following the last session’s upward trend.
About ABL Diagnostics
ABL Diagnostics Société anonyme does not have significant operations. The company was formerly known as Etablissements Fauvet Girel and changed its name to ABL Diagnostics Société anonyme in April 2022. The company is headquartered in Paris, France. ABL Diagnostics Société anonyme is a subsidiary of Advanced Biological Laboratories (ABL) S.A.
Volatility
ABL Diagnostics’s last week, last month’s, and last quarter’s current intraday variation average was a negative 10.69%, a negative 10.82%, and a positive 13.62%.
ABL Diagnostics’s highest amplitude of average volatility was 10.69% (last week), 10.82% (last month), and 13.62% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ABL Diagnostics’s stock is considered to be overbought (>=80).
More news about ABL Diagnostics (ABLD.PA).
